Last news
Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis

Lynk Pharmaceuticals Announces Positive Phase III Topline Data of Zemprocitinib in Moderate-to-Severe Atopic Dermatitis

SHANGHAI, HANGZHOU, China and BOSTON, March 2, 2026 /PRNewswire/ -- Lynk Pharmaceuticals Co., Ltd. ("Lynk Pharmaceuticals"), a clinical-stage innovative drug development company focused on therapies for immune and inflammatory diseases, today...

Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves

Toku Reports US$34.8 million Revenue in FY2025 as AI Adoption Gains Traction; Underlying Loss Improves

SINGAPORE, March 2, 2026 /PRNewswire/ -- Toku Ltd. ("Toku", "投酷有限公司" or the "Company", and together with its subsidiaries, the "Group"), a Singapore-incorporated AI-powered customer experience (CX) platform, is pleased to announce its financial...

Understanding China's whole-process people's democracy

Understanding China's whole-process people's democracy

BEIJING, March 2, 2026 /PRNewswire/ -- A report from People's Daily: The upcoming "two sessions," the annual meetings of China's top legislature, the National People's Congress (NPC), and the top political advisory body, the National Committee of...

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Jaypirca® (Pirtobrutinib) Approved in China for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

SAN FRANCISCO and SUZHOU, China, March 2, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of...

Investor Education Webinar

Investor Education Webinar

The Future of Prostate Imaging: What do physicians want? MELBOURNE, Australia and INDIANAPOLIS, March 2, 2026 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") invites investors to join a webinar with key opinion leaders...

Trip.com's Go Explore Mega Sale Set to Launch - Save on Flights, Hotels, Tours & More

Trip.com's Go Explore Mega Sale Set to Launch - Save on Flights, Hotels, Tours & More

SYDNEY, March 2, 2026 /PRNewswire/ -- Trip.com's Go Explore Mega Sale is set to take off, bringing massive savings to travellers across flights, hotels, attractions, eSIMs, car hire, airport transfers and trains. Customers can subscribe to deals now...

Say Hello to Speed: The Baseus PicoGo AM52 Qi2.2 Magnetic Power Bank Slim

Say Hello to Speed: The Baseus PicoGo AM52 Qi2.2 Magnetic Power Bank Slim

SHENZHEN, China, March 1, 2026 /PRNewswire/ -- At Baseus, the commitment to user needs shines through in every product design. With values that focus on innovation and versatile lifestyles, Baseus prioritizes original, minimalistic, and efficient...

Acwa Board of Directors names Dr. Samir J. Serhan Chief Executive Officer

Acwa Board of Directors names Dr. Samir J. Serhan Chief Executive Officer

Dr. Samir J. Serhan named CEO effective today by Acwa Board of Directors. Dr. Serhan was previously President of Saudi Arabia and the Middle East at Acwa, and formerly Chief Operating Officer of US-based Air Products. Marco Arcelli, CEO of Acwa...

1 ... 9 10 11 12 13 14 15 16 17 ... 3845
menu
menu